The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant strategic advice and guidance.
The current membership of the Strategic Advisory Board is as follows:
- Chair: Mike Snowden, Independent
- Graham Bond, Liverpool/Chester Office Managing Partner, RSM
- Ben Cliff, CEO, Concept Life Sciences
- Chris Doherty, Independent
- Claire Eyers, Associate Pro Vice Chancellor (Research & Impact), University of Liverpool
- Paul Found, COO, Fujifilm Diosynth Biotechnologies
- James Fry, Partner - Head of Life Sciences, Mills & Reeve
- Catherine Headley, Head of Business Engagement and Knowledge Exchange, University of Manchester
- Ellen Hewitt, Head of Innovation and Business Development, University of Leeds
- Nige Hilton, Head of Manufacturing and Site Leader, Seqirus
- Nathalie Huther, Associate Vice President Business Development, Sai Life Sciences
- Kath Mackay, Chief Scientific Officer, Bruntwood SciTech
- Steve McConchie, Independent
- Neil Murray, CEO, Impact Data Metrics
- Jonathan O'Halloran, CEO, QuantuMDx
- Jonathan Perkins, Director : Global Development Lead, QIAGEN
- Linda Randall, Associate Vice President, Pharmaron
- Dave Simpson, CEO, Iksuda Therapeutics
- Peter Simpson, Independent
- Joe de Sousa, Independent
- Simon Wallwork, Partner, Slater Heelis
Latest Jobs
